Karl Melber
- Immunology top 5%
- Molecular Biology
- Epidemiology top 5%
- Hepatology top 5%
- Infectious Diseases top 10%
- Co-authors
- Jörg ReimannReinhold SchirmbeckZbigniew A. JanowiczThomas MertensGerd GellissenW BöhmCornelis P. HollenbergAndreas Kuhröber
- Topics
- Immunotherapy and Immune Responses (12 papers)Hepatitis B Virus Studies (10 papers)Immune Response and Inflammation (4 papers)
- Cited by
- ImmunologyHepatologyEpidemiology
- Journals
- Proceedings of the National Academy of SciencesThe Journal of ImmunologyJournal of Virology
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Karl Melber
24 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 86
- Immunology 750
- Molecular Biology 654
- Epidemiology 543
- Hepatology 201
- Infectious Diseases 129
Countries citing papers authored by Karl Melber
This map shows the geographic impact of Karl Melber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Melber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Melber more than expected).
Fields of papers citing papers by Karl Melber
This network shows the impact of papers produced by Karl Melber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Melber. The network helps show where Karl Melber may publish in the future.
Co-authorship network of co-authors of Karl Melber
This figure shows the co-authorship network connecting the top 25 collaborators of Karl Melber. A scholar is included among the top collaborators of Karl Melber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Melber. Karl Melber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 72 | |
| 2 | 28 | |
| 3 | 36 | |
| 4 | 87 | |
| 5 | 28 | |
| 6 | 93 | |
| 7 | 7 | |
| 8 | 15 | |
| 9 | Methylotrophic yeast hansenula polymorpha as production organism for recombinant pharmaceuticals. | 33 |
| 10 | 129 | |
| 11 | 88 | |
| 12 | 82 | |
| 13 | 51 | |
| 14 | 140 | |
| 15 | 86 | |
| 16 | 60 | |
| 17 | 33 | |
| 18 | 118 | |
| 19 | 146 | |
| 20 | 38 |
About Karl Melber
Karl Melber is a scholar working on Immunology, Biotechnology and Epidemiology, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Hepatitis B Virus Studies (10 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Immunology (750 citations), Hepatology (201 citations) and Epidemiology (543 citations). Karl Melber has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Jörg Reimann, Reinhold Schirmbeck, Zbigniew A. Janowicz, Thomas Mertens, Gerd Gellissen, W Böhm, Cornelis P. Hollenberg, Andreas Kuhröber, R. Kath and Meenhard Herlyn. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.